These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11134642)

  • 1. Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat.
    Kask A; Schiöth HB
    Brain Res; 2000 Dec; 887(2):460-4. PubMed ID: 11134642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands.
    Giraudo SQ; Billington CJ; Levine AS
    Brain Res; 1998 Nov; 809(2):302-6. PubMed ID: 9853124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior.
    Strader AD; Schiöth HB; Buntin JD
    Brain Res; 2003 Jan; 960(1-2):112-21. PubMed ID: 12505663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats.
    Vergoni AV; Bertolini A; Mutulis F; Wikberg JE; Schiöth HB
    Eur J Pharmacol; 1998 Dec; 362(2-3):95-101. PubMed ID: 9874158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia.
    Beckman TR; Shi Q; Levine AS; Billington CJ
    Physiol Behav; 2009 Mar; 96(4-5):568-73. PubMed ID: 19136019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
    Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
    Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y.
    Kask A; Rägo L; Korrovits P; Wikberg JE; Schiöth HB
    Biochem Biophys Res Commun; 1998 Jul; 248(2):245-9. PubMed ID: 9675121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat.
    Giraudo SQ; Billington CJ; Levine AS
    Brain Res; 1998 Jan; 782(1-2):18-23. PubMed ID: 9519245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action.
    Dube MG; Kalra SP; Kalra PS
    Brain Res; 1999 Sep; 842(2):473-7. PubMed ID: 10526145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat.
    Corwin RL; Robinson JK; Crawley JN
    Eur J Neurosci; 1993 Nov; 5(11):1528-33. PubMed ID: 7506975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats.
    Kask A; Rägo L; Mutulis F; Pähkla R; Wikberg JE; Schiöth HB
    Biochem Biophys Res Commun; 1998 Apr; 245(1):90-3. PubMed ID: 9535789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin activity in the amygdala influences alcohol intake.
    York DA; Boghossian S; Park-York M
    Pharmacol Biochem Behav; 2011 Mar; 98(1):112-9. PubMed ID: 21167196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage.
    Vergoni AV; Bertolini A; Wikberg JE; Schiöth HB
    Peptides; 1999; 20(4):509-13. PubMed ID: 10458522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of MT-II on ghrelin-induced feeding in the paraventricular nucleus of the hypothalamus.
    Shrestha YB; Wickwire K; Giraudo SQ
    Neuroreport; 2004 Jun; 15(8):1365-7. PubMed ID: 15167567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons.
    Katsurada K; Maejima Y; Nakata M; Kodaira M; Suyama S; Iwasaki Y; Kario K; Yada T
    Biochem Biophys Res Commun; 2014 Aug; 451(2):276-81. PubMed ID: 25089000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an interaction between neuropeptide Y and the melanocortin-4 receptor on feeding in the rat.
    Hansen MJ; Morris MJ
    Neuropharmacology; 2002 May; 42(6):792-7. PubMed ID: 12015205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feeding behavior after metergoline or GR-46611 injections into the paraventricular nucleus of the hypothalamus in the pigeon.
    Da Silva RA; Da Silva AS; Poffo MJ; Ribas DC; Faria MS; Marino-Neto J; Paschoalini MA
    Behav Brain Res; 2007 May; 179(2):248-57. PubMed ID: 17360049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
    Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
    Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.